ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Bicara Therapeutics Inc

Bicara Therapeutics Inc (BCAX)

20,00
-0,41
(-2,01%)
Geschlossen 06 Juni 10:00PM
20,01
0,01
(0,05%)
Nach Börsenschluss: 1:59AM

Bicara Therapeutics Inc (BCAX) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
20,00
( -2,01% )
Gebot
6,34
Fragen
31,76
Volumen
356.204
19,91 Tagesbereich 20,42
8,48 52-Wochen-Bereich 24,25
Marktkapitalisierung
Handelsende
20,41
Handelsbeginn
20,28
Letzte Trade
14
@
20
Letzter Handelszeitpunkt
Finanzvolumen
US$ 7.181.258
VWAP
20,1605
Durchschnittliches Volumen (3 Mio.)
US$ 554.394
Ausgegebene Aktien
65.703.866
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-7,78
Gewinn pro Aktie (EPS)
-2,8
Erlöse (LTM)
-
Nettogewinn (LTM)
-157,32M

Über Bicara Therapeutics Inc

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody... Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Website
Hauptsitz
Boston, United States
Gegründet
2026
Bicara Therapeutics Inc is listed in the Healthcare sector of the NASDAQ with ticker BCAX. The last closing price for Bicara Therapeutics was US$20,41. Over the last year, Bicara Therapeutics shares have traded in a share price range of US$ 8,48 to US$ 24,25.

Bicara Therapeutics currently has 65.703.866 shares in issue. The market capitalisation of Bicara Therapeutics is US$1,31 billion. Bicara Therapeutics has a price to earnings ratio (PE ratio) of -7.78.

BCAX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.63-7.5358298659321.6321.9919.0952092420.36492069CS
4-3.07-13.30732553123.0723.7818.6257571020.96508632CS
120.593.0396702730619.4124.2517.6353268921.05169383CS
261.15.8201058201118.924.2513.7554534519.04625675CS
528.8779.694519317211.1324.258.4855555916.21279922CS
156-6.25-23.809523809526.2528.097.855698315.7615761CS
260-6.25-23.809523809526.2528.097.855698315.7615761CS

BCAX - Frequently Asked Questions (FAQ)

What is the current Bicara Therapeutics Inc share price?
The current share price of Bicara Therapeutics Inc is US$ 20,00
How many Bicara Therapeutics Inc shares are in issue?
Bicara Therapeutics Inc has 65.703.866 shares in issue
What is the market cap of Bicara Therapeutics Inc?
The market capitalisation of Bicara Therapeutics Inc is USD 1,31B
What is the 1 year trading range for Bicara Therapeutics Inc share price?
Bicara Therapeutics Inc has traded in the range of US$ 8,48 to US$ 24,25 during the past year
What is the PE ratio of Bicara Therapeutics Inc?
The price to earnings ratio of Bicara Therapeutics Inc is -7,78
What is the registered address of Bicara Therapeutics Inc?
The registered address for Bicara Therapeutics Inc is 116 Huntington Avenue, Boston, Massachusetts, 02116
What is the Bicara Therapeutics Inc website address?
The website address for Bicara Therapeutics Inc is www.bicara.com
Which industry sector does Bicara Therapeutics Inc operate in?
Bicara Therapeutics Inc operates in the Biotechnology & Life Sciences sector

BCAX Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen